Nuwellis Ownership
| NUWE Stock | USD 1.16 0.01 0.87% |
Shares in Circulation | First Issued 2011-03-31 | Previous Quarter 1.4 M | Current Value 3.4 M | Avarage Shares Outstanding 338.7 K | Quarterly Volatility 1 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Nuwellis |
Nuwellis Stock Ownership Analysis
The company has price-to-book ratio of 0.78. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Nuwellis recorded a loss per share of 8.41. The entity last dividend was issued on the 19th of October 2020. The firm had 1:35 split on the 28th of June 2024. Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota. Nuwellis operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 70 people. To find out more about Nuwellis contact Nestor Jaramillo at 952 345 4200 or learn more at https://www.nuwellis.com.Besides selling stocks to institutional investors, Nuwellis also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Nuwellis' stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Nuwellis' strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Nuwellis Quarterly Liabilities And Stockholders Equity |
|
Less than 1% of Nuwellis are currently held by insiders. Unlike Nuwellis' institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Nuwellis' private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Nuwellis' insider trades
Nuwellis Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Nuwellis is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Nuwellis backward and forwards among themselves. Nuwellis' institutional investor refers to the entity that pools money to purchase Nuwellis' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | |||
| Geode Capital Management, Llc | 2024-12-31 | 30.8 K | |
| Hrt Financial Llc | 2024-12-31 | 0.0 | |
| Ubs Group Ag | 2024-12-31 | 23.2 K | |
| Citadel Advisors Llc | 2024-12-31 | 11.8 K | |
| Two Sigma Securities, Llc | 2024-12-31 | 11.3 K | |
| Tower Research Capital Llc | 2024-12-31 | 4.8 K | |
| Sbi Securities Co Ltd | 2024-12-31 | 547 | |
| Bank Of America Corp | 2024-12-31 | 37.0 | |
| Morgan Stanley - Brokerage Accounts | 2024-12-31 | 0.0 | |
| Qube Research & Technologies | 2024-09-30 | 0.0 | |
| Wells Fargo & Co | 2024-09-30 | 0.0 |
Nuwellis Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Nuwellis insiders, such as employees or executives, is commonly permitted as long as it does not rely on Nuwellis' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Nuwellis insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Nuwellis Outstanding Bonds
Nuwellis issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Nuwellis uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Nuwellis bonds can be classified according to their maturity, which is the date when Nuwellis has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| OCINV 67 16 MAR 33 Corp BondUS67116NAA72 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Nuwellis is a strong investment it is important to analyze Nuwellis' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Nuwellis' future performance. For an informed investment choice regarding Nuwellis Stock, refer to the following important reports:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nuwellis. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. For information on how to trade Nuwellis Stock refer to our How to Trade Nuwellis Stock guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nuwellis. If investors know Nuwellis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nuwellis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (8.41) | Revenue Per Share | Quarterly Revenue Growth (0.09) | Return On Assets | Return On Equity |
The market value of Nuwellis is measured differently than its book value, which is the value of Nuwellis that is recorded on the company's balance sheet. Investors also form their own opinion of Nuwellis' value that differs from its market value or its book value, called intrinsic value, which is Nuwellis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nuwellis' market value can be influenced by many factors that don't directly affect Nuwellis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nuwellis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Nuwellis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nuwellis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.